Research ArticleClinical Investigation
Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
Zahra Sabahi, Andrew Nguyen, Keith Wong, Sherrington Li, Nathan Papa, Elgene Lim, Rachel F. Dear, Alexander M. Menzies, Frances Boyle, Yoland Antill, Belinda E. Kiely, Benjamin C. Forster, Cindy Mak, Diana Adams, Lina Pugliano, Andrew Spillane, Shikha Sharma, Adam Hickey, Aron Poole, Shikha Agrawal, Sobia Khan, Narjess Ayati and Louise Emmett
Journal of Nuclear Medicine March 2025, jnumed.124.268896; DOI: https://doi.org/10.2967/jnumed.124.268896
Zahra Sabahi
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
2Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;
Andrew Nguyen
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
3St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;
Keith Wong
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Sherrington Li
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Nathan Papa
2Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;
Elgene Lim
3St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;
Rachel F. Dear
3St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;
4Department of Medical Oncology, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Alexander M. Menzies
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
6Mater Hospital, Wollstonecraft, New South Wales, Australia;
Frances Boyle
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
6Mater Hospital, Wollstonecraft, New South Wales, Australia;
Yoland Antill
7Department of Medical Oncology, Peninsula Health, Frankston, Victoria, Australia;
8Faculty of Medicine and Health Sciences, Monash University, Clayton, Victoria, Australia;
Belinda E. Kiely
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
9Department of Medical Oncology, Campbelltown Hospital, Campbelltown, New South Wales, Australia; and
Benjamin C. Forster
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
6Mater Hospital, Wollstonecraft, New South Wales, Australia;
Cindy Mak
10Chris O’Brian Lifehouse, Camperdown, New South Wales, Australia
Diana Adams
9Department of Medical Oncology, Campbelltown Hospital, Campbelltown, New South Wales, Australia; and
Lina Pugliano
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
6Mater Hospital, Wollstonecraft, New South Wales, Australia;
Andrew Spillane
5Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia;
6Mater Hospital, Wollstonecraft, New South Wales, Australia;
Shikha Sharma
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Adam Hickey
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Aron Poole
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Shikha Agrawal
2Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;
Sobia Khan
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
Narjess Ayati
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
2Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;
3St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;
Louise Emmett
1Theranostics and Nuclear Medicine Department, St Vincent’s Hospital Sydney, Darlinghurst, New South Wales, Australia;
2Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;
3St Vincent’s Clinical School, University of New South Wales, Sydney, New South Wales, Australia;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
Zahra Sabahi, Andrew Nguyen, Keith Wong, Sherrington Li, Nathan Papa, Elgene Lim, Rachel F. Dear, Alexander M. Menzies, Frances Boyle, Yoland Antill, Belinda E. Kiely, Benjamin C. Forster, Cindy Mak, Diana Adams, Lina Pugliano, Andrew Spillane, Shikha Sharma, Adam Hickey, Aron Poole, Shikha Agrawal, Sobia Khan, Narjess Ayati, Louise Emmett
Journal of Nuclear Medicine Mar 2025, jnumed.124.268896; DOI: 10.2967/jnumed.124.268896
Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
Zahra Sabahi, Andrew Nguyen, Keith Wong, Sherrington Li, Nathan Papa, Elgene Lim, Rachel F. Dear, Alexander M. Menzies, Frances Boyle, Yoland Antill, Belinda E. Kiely, Benjamin C. Forster, Cindy Mak, Diana Adams, Lina Pugliano, Andrew Spillane, Shikha Sharma, Adam Hickey, Aron Poole, Shikha Agrawal, Sobia Khan, Narjess Ayati, Louise Emmett
Journal of Nuclear Medicine Mar 2025, jnumed.124.268896; DOI: 10.2967/jnumed.124.268896
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.